Multimodal VQA Model Predicts Prostate Cancer Survival After Therapy

A TUM and Bern University Hospital team framed survival prognosis after PSMA radioligand therapy as a visual question answering task, using baseline and interim PET/SPECT imaging plus PSA and clinical data to predict 24-month survival in prostate cancer, published in the Journal of Nuclear Medicine.

2026-10-20 ~ 2026-10-20 · 2 related posts

• Framing Cancer Survival Prognosis as VQA: PET Scans + PSA Predict 24-Month Survival — maier_ak · 2026-10-20
• TUM team frames PET scans as visual Q&A to predict 24-month survival in PSMA prostate cancer therapy — maier_ak · 2026-10-20